| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1843* | 2021 |
| Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ... Journal of medical genetics 44 (2), 81-88, 2007 | 1174 | 2007 |
| Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification JD Fine, L Bruckner-Tuderman, RAJ Eady, EA Bauer, JW Bauer, C Has, ... Journal of the American Academy of Dermatology 70 (6), 1103-1126, 2014 | 1053 | 2014 |
| The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data S Köhler, SC Doelken, CJ Mungall, S Bauer, HV Firth, I Bailleul-Forestier, ... Nucleic acids research 42 (D1), D966-D974, 2014 | 912 | 2014 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 617* | 2021 |
| A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO) J Zonana, ME Elder, LC Schneider, SJ Orlow, C Moss, M Golabi, ... The American Journal of Human Genetics 67 (6), 1555-1562, 2000 | 578 | 2000 |
| Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility C Has, JW Bauer, C Bodemer, MC Bolling, L Bruckner‐Tuderman, A Diem, ... British Journal of Dermatology 183 (4), 614-627, 2020 | 549 | 2020 |
| Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis PD Kelsell, EE Norgett, H Unsworth, MT Teh, T Cullup, CA Mein, ... The American Journal of Human Genetics 76 (5), 794-803, 2005 | 435 | 2005 |
| Naevi and other developmental defects DJ Atherton, C Moss Rook's textbook of dermatology, 569-682, 2004 | 363 | 2004 |
| Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis K Batta, HM Goodyear, C Moss, HC Williams, L Hiller, R Waters The Lancet 360 (9332), 521-527, 2002 | 339 | 2002 |
| Proactive disease management with 0· 03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study D Thaci, S Reitamo, MA Gonzalez Ensenat, C Moss, V Boccaletti, ... British journal of dermatology 159 (6), 1348-1356, 2008 | 268 | 2008 |
| Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy L Al-Olabi, S Polubothu, K Dowsett, KA Andrews, P Stadnik, AP Joseph, ... The Journal of clinical investigation 128 (4), 1496-1508, 2018 | 254 | 2018 |
| Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases S Rajpopat, C Moss, J Mellerio, A Vahlquist, A Gånemo, M Hellstrom-Pigg, ... Archives of dermatology 147 (6), 681-686, 2011 | 242 | 2011 |
| The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia DC Blaydon, Y Ishii, EA O'Toole, HC Unsworth, MT Teh, F Rüschendorf, ... Nature genetics 38 (11), 1245-1247, 2006 | 218 | 2006 |
| Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex FJD Smith, LD Corden, EL Rugg, R Ratnavel, IM Leigh, C Moss, ... Journal of investigative dermatology 108 (2), 220-223, 1997 | 185 | 1997 |
| Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. PS Friedmann, C Moss, S Shuster, JM Simpson Clinical and experimental immunology 53 (3), 709, 1983 | 176 | 1983 |
| 0· 03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a … S Reitamo, J Harper, JD Bos, F Cambazard, C Bruijnzeel‐Koomen, ... British Journal of Dermatology 150 (3), 554-562, 2004 | 175 | 2004 |
| Deletion of the SLUG (SNAI2) gene results in human piebaldism M Sánchez‐Martín, J Pérez‐Losada, A Rodríguez‐García, ... American Journal of Medical Genetics Part A 122 (2), 125-132, 2003 | 150 | 2003 |
| Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism K Ezoe, SA Holmes, L Ho, CP Bennett, JL Bolognia, L Brueton, J Burn, ... American journal of human genetics 56 (1), 58, 1995 | 144 | 1995 |
| Pseudoxanthoma elasticum S Laube, C Moss Archives of disease in childhood 90 (7), 754-756, 2005 | 142 | 2005 |
